Search Results

There are 21925 results for: content related to: Human papillomavirus seropositivity and risks of head and neck cancer

  1. You have full text access to this OnlineOpen article
    Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15–55 years and first-time modelling of antibody responses in mature women: results from an open-label 6–year follow-up study

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 122, Issue 1, January 2015, Pages: 107–118, T Schwarz, M Spaczynski, A Kaufmann, J Wysocki, A Gałaj, K Schulze, P Suryakiran, F Thomas and D Descamps

    Version of Record online : 11 SEP 2014, DOI: 10.1111/1471-0528.13070

  2. You have free access to this content
    Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women

    International Journal of Cancer

    Volume 129, Issue 9, 1 November 2011, Pages: 2147–2157, Tiina Petäjä, Court Pedersen, Airi Poder, Gitte Strauss, Gregory Catteau, Florence Thomas, Matti Lehtinen and Dominique Descamps

    Version of Record online : 11 MAR 2011, DOI: 10.1002/ijc.25887

  3. You have free access to this content
    Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody

    International Journal of Cancer

    Volume 113, Issue 1, 1 January 2005, Pages: 93–100, Dai-Wei Liu, Junn-Liang Chang, Yeou-Ping Tsao, Chien-Wei Huang, Shu-Wen Kuo and Show-Li Chen

    Version of Record online : 25 AUG 2004, DOI: 10.1002/ijc.20530

  4. You have free access to this content
    Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer

    International Journal of Cancer

    Volume 97, Issue 6, 20 February 2002, Pages: 796–803, Alba-Lucia Combita, Maria-Mercedes Bravo, Antoine Touzé, Oscar Orozco and Pierre Coursaget

    Version of Record online : 7 DEC 2001, DOI: 10.1002/ijc.10153

  5. You have full text access to this Open Access content
    Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras

    Plant Biotechnology Journal

    Volume 11, Issue 8, October 2013, Pages: 964–975, Catherine B. Pineo, Inga I. Hitzeroth and Edward P. Rybicki

    Version of Record online : 7 AUG 2013, DOI: 10.1111/pbi.12089

  6. You have free access to this content
    A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US

    Cancer

    Volume 113, Issue S10, 15 November 2008, Pages: 2995–3003, Eileen F. Dunne, S. Deblina Datta and Lauri E. Markowitz

    Version of Record online : 3 NOV 2008, DOI: 10.1002/cncr.23763

  7. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women

    Journal of Obstetrics and Gynaecology Research

    Volume 36, Issue 1, February 2010, Pages: 123–132, Neerja Bhatla, Vanita Suri, Partha Basu, Surendra Shastri, Sanjoy K. Datta, Dan Bi, Dominique J. Descamps, Hans L. Bock and the Indian HPV Vaccine Study Group

    Version of Record online : 4 FEB 2010, DOI: 10.1111/j.1447-0756.2009.01167.x

    Corrected by:

    Erratum

    Vol. 36, Issue 2, 466, Version of Record online: 25 MAR 2010

  8. You have free access to this content
    Enhancement of vaccine potency by fusing modified LTK63 into human papillomavirus type 16 chimeric virus-like particles

    FEMS Immunology & Medical Microbiology

    Volume 52, Issue 1, January 2008, Pages: 99–109, Yufei Xu, Hongtao Zhang and Xuemei Xu

    Version of Record online : 8 NOV 2007, DOI: 10.1111/j.1574-695X.2007.00339.x

  9. You have free access to this content
    Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions

    International Journal of Cancer

    Volume 122, Issue 2, 15 January 2008, Pages: 247–259, Shreya Kanodia, Diane M. Da Silva and W. Martin Kast

    Version of Record online : 31 OCT 2007, DOI: 10.1002/ijc.23252

  10. You have free access to this content
    Combined prophylactic and therapeutic cancer vaccine: Enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice

    International Journal of Cancer

    Volume 118, Issue 12, 15 June 2006, Pages: 3022–3029, Jiahua Qian, Yujun Dong, Yuk-Ying S. Pang, Ramy Ibrahim, Jay A. Berzofsky, John T. Schiller and Samir N. Khleif

    Version of Record online : 19 JAN 2006, DOI: 10.1002/ijc.21781

  11. You have full text access to this OnlineOpen article
    Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial

    International Journal of Cancer

    Volume 135, Issue 11, 1 December 2014, Pages: 2612–2622, Feng-Cai Zhu, Wen Chen, Yue-Mei Hu, Ying Hong, Juan Li, Xun Zhang, Yi-Ju Zhang, Qin-Jing Pan, Fang-Hui Zhao, Jia-Xi Yu, Yan-Shu Zhang, Xiaoping Yang, Cheng-Fu Zhang, Haiwen Tang, Helen Zhang, Marie Lebacq, Marie-Pierre David, Sanjoy K Datta, Frank Struyf, Dan Bi, Dominique Descamps and for the HPV-039 study group

    Version of Record online : 19 MAY 2014, DOI: 10.1002/ijc.28897

  12. You have free access to this content
    Production of recombinant virus-like particles from human papillomavirus types 6 and 11, and study of serological reactivities between HPV 6, 11, 16 and 45 by ELISA: implications for papillomavirus prevention and detection

    FEMS Microbiology Letters

    Volume 160, Issue 1, March 1998, Pages: 111–118, Antoine Touzé, Catherine Dupuy, Dominique Mahé, Pierre-Yves Sizaret and Pierre Coursaget

    Version of Record online : 17 JAN 2006, DOI: 10.1111/j.1574-6968.1998.tb12899.x

  13. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children

    Journal of Medical Virology

    Volume 79, Issue 9, September 2007, Pages: 1370–1374, Dianne J. Marais, Candice C. Sampson, Margaret I. Urban, Freddy Sitas and Anna-Lise Wiliamson

    Version of Record online : 2 JUL 2007, DOI: 10.1002/jmv.20874

  14. You have full text access to this OnlineOpen article
    Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18–25 years enrolled in a clinical trial

    International Journal of Cancer

    Volume 135, Issue 11, 1 December 2014, Pages: 2604–2611, Fang-Hui Zhao, Feng-Cai Zhu, Wen Chen, Juan Li, Yue-Mei Hu, Ying Hong, Yi-Ju Zhang, Qin-Jing Pan, Jia-Hong Zhu, Xun Zhang, Yong Chen, Haiwen Tang, Helen Zhang, Christelle Durand, Sanjoy K. Datta, Frank Struyf, Dan Bi and for the HPV-039 study group

    Version of Record online : 20 MAY 2014, DOI: 10.1002/ijc.28896

  15. You have free access to this content
    Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18

    International Journal of Cancer

    Volume 131, Issue 1, 1 July 2012, Pages: 106–116, A. Szarewski, W.A.J. Poppe, S.R. Skinner, C.M. Wheeler, J. Paavonen, P. Naud, J. Salmeron, S.-N. Chow, D. Apter, H. Kitchener, X. Castellsagué, J.C. Teixeira, J. Hedrick, U. Jaisamrarn, G. Limson, S. Garland, B. Romanowski, F.Y. Aoki, T.F. Schwarz, F.X. Bosch, D.M. Harper, K. Hardt, T. Zahaf, D. Descamps, F. Struyf, M. Lehtinen, G. Dubin and for the HPV PATRICIA Study Group

    Version of Record online : 23 OCT 2011, DOI: 10.1002/ijc.26362

  16. You have free access to this content
    Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions

    International Journal of Cancer

    Volume 75, Issue 4, 9 February 1998, Pages: 529–535, Toshiyuki Sasagawa, Hiroshi Yamazaki, Yu-Zhen Dong, Shin-ichirou Satake, Masaya Tateno and Masaki Inoue

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19980209)75:4<529::AID-IJC7>3.0.CO;2-V

  17. You have free access to this content
    Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer

    International Journal of Cancer

    Volume 127, Issue 1, 1 July 2010, Pages: 111–117, Elaine M. Smith, Michael Pawlita, Linda M. Rubenstein, Thomas H. Haugen, Eva Hamsikova and Lubomir P. Turek

    Version of Record online : 28 OCT 2009, DOI: 10.1002/ijc.25015

  18. You have free access to this content
    Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine

    European Journal of Immunology

    Volume 36, Issue 2, February 2006, Pages: 437–445, Alfonso J. García-Piñeres, Allan Hildesheim, Matthew Trivett, Marcus Williams, Li Wu, Vineet N. KewalRamani and Ligia A. Pinto

    Version of Record online : 30 DEC 2005, DOI: 10.1002/eji.200535068

  19. You have free access to this content
    Cervical cancer vaccines: Emerging concepts and developments

    Journal of Cellular Physiology

    Volume 186, Issue 2, February 2001, Pages: 169–182, Diane M. Da Silva, Gretchen L. Eiben, Steven C. Fausch, Mark T. Wakabayashi, Michael P. Rudolf, Markwin P. Velders and W. Martin Kast

    Version of Record online : 11 JAN 2001, DOI: 10.1002/1097-4652(200102)186:2<169::AID-JCP1023>3.0.CO;2-H

  20. Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions?

    Journal of Medical Virology

    Volume 84, Issue 7, July 2012, Pages: 1128–1134, Hiroyuki Ochi, Koji Matsumoto, Kazunari Kondo, Akinori Oki, Reiko Furuta, Yasuo Hirai, Toshiharu Yasugi, Naoyoshi Takatsuka, Hiroo Maeda, Akira Mitsuhashi, Takuma Fujii, Kei Kawana, Tsuyoshi Iwasaka, Nobuo Yaegashi, Yoh Watanabe, Yutaka Nagai, Tomoyuki Kitagawa, Tadahito Kanda, Hiroyuki Yoshikawa and for Japan HPV And Cervical Cancer (JHACC) Study Group

    Version of Record online : 14 MAY 2012, DOI: 10.1002/jmv.23258